Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by GAMMA Investing LLC

GAMMA Investing LLC raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 4,683.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,342 shares of the company's stock after buying an additional 62,997 shares during the period. GAMMA Investing LLC owned about 0.05% of Privia Health Group worth $1,444,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Rhumbline Advisers raised its stake in Privia Health Group by 1.3% in the fourth quarter. Rhumbline Advisers now owns 287,200 shares of the company's stock valued at $5,615,000 after buying an additional 3,658 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in Privia Health Group by 8.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock valued at $140,000 after buying an additional 533 shares in the last quarter. Versor Investments LP acquired a new stake in Privia Health Group in the fourth quarter valued at $721,000. Dimensional Fund Advisors LP raised its stake in Privia Health Group by 10.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock valued at $27,687,000 after buying an additional 138,747 shares in the last quarter. Finally, Durable Capital Partners LP raised its stake in Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock valued at $224,587,000 after buying an additional 378,255 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have recently commented on PRVA. Robert W. Baird lifted their target price on Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Canaccord Genuity Group lifted their target price on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Truist Financial lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Barclays lifted their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 27th. Finally, JMP Securities reiterated a "market outperform" rating and set a $29.00 target price on shares of Privia Health Group in a research report on Monday, April 28th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Buy" and an average target price of $27.77.

Insider Activity

In related news, Director Matthew Shawn Morris sold 10,309 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $240,508.97. Following the completion of the sale, the director now directly owns 59,792 shares in the company, valued at approximately $1,394,947.36. This trade represents a 14.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO David Mountcastle sold 3,445 shares of the stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $80,371.85. Following the completion of the sale, the chief financial officer now owns 176,231 shares of the company's stock, valued at approximately $4,111,469.23. The trade was a 1.92% decrease in their position. The disclosure for this sale can be found here. Insiders sold 51,579 shares of company stock worth $1,226,367 over the last three months. Corporate insiders own 10.70% of the company's stock.

Privia Health Group Trading Down 0.2%

Shares of NASDAQ:PRVA opened at $22.65 on Friday. The firm's 50 day moving average is $23.46 and its two-hundred day moving average is $22.83. Privia Health Group, Inc. has a 52 week low of $16.37 and a 52 week high of $26.09. The firm has a market capitalization of $2.76 billion, a P/E ratio of 226.52, a PEG ratio of 3.47 and a beta of 0.83.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.